Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.

Literature DB >> 27914833

Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.

Jing Feng¹, Jing Qian², Yanrong Jiang³, Mingwei Zhao⁴, Jianhong Liang⁴, Hong Yin⁴, Yi Chen⁵, Wenzhen Yu⁴, Xiaoxin Li⁶.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2016 PMID： 27914833 DOI： 10.1016/j.ophtha.2016.10.032

Source DB: PubMed Journal: Ophthalmology ISSN： 0161-6420 Impact factor: 12.079

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab.

Authors: Jiao Lyu; Qi Zhang; Haiying Jin; Yu Xu; Chunli Chen; Xunda Ji; Xiang Zhang; Yuqing Rao; Peiquan Zhao
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-06-09 Impact factor: 3.117

2. Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3^.

Authors: Xiu-Mei Yang; Yue-Xiang Zhao; Zong-Hua Wang; Lu Liu
Journal: Int J Ophthalmol Date: 2018-04-18 Impact factor: 1.779

3. Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity.

Authors: Qiong Zou; Yan-Qiong Zhu; Feng-Jun Zhang; Qiu-Ping Liu
Journal: Int J Ophthalmol Date: 2022-05-18 Impact factor: 1.779

Review 4. Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy.

Authors: Nita G Valikodath; Michael F Chiang; R V Paul Chan
Journal: Curr Opin Ophthalmol Date: 2021-09-01 Impact factor: 4.299

5. Clinical outcome following reinjection of Ranibizumab for reactivation of retinopathy of prematurity.

Authors: Rania M Bassiouny; Walid M Gaafar; Amgad El Nokrashy; Ameera G Abdelhameed; Eman A Attallah; Ahmed G Elgharieb; Mohamed R Bassiouny
Journal: Eye (Lond) Date: 2021-10-28 Impact factor: 4.456

6. Repeated intravitreal ranibizumab for reactivated retinopathy of prematurity after intravitreal ranibizumab monotherapy: vascular development analysis.

Authors: Fengjie Xia; Jiao Lyu; Jie Peng; Peiquan Zhao
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2022-04-19 Impact factor: 3.535

7. Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity.

Authors: Amir Eftekhari Milani; Narges Hassanpoor; Mohammadreza Mousavi Mirkala; Arash Taheri; Ali Golizade; Mohamad Reza Niyousha
Journal: Int Ophthalmol Date: 2019-11-11 Impact factor: 2.031